Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
3(27%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
3
27%
Ph phase_2
5
45%
Ph not_applicable
3
27%

Phase Distribution

3

Early Stage

5

Mid Stage

0

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
3(27.3%)
Phase 2Efficacy & side effects
5(45.5%)
N/ANon-phased studies
3(27.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

3

trials recruiting

Total Trials

11

all time

Status Distribution
Active(3)
Completed(4)
Terminated(1)
Other(3)

Detailed Status

Completed4
unknown3
Recruiting2
Withdrawn1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
3
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 13 (27.3%)
Phase 25 (45.5%)
N/A3 (27.3%)

Trials by Status

recruiting218%
unknown327%
withdrawn19%
active_not_recruiting19%
completed436%

Recent Activity

3 active trials
Showing 5 of 11
recruitingnot_applicable

ONC-LEUK-2406: The Impact of Systematic Financial Navigation in Acute Myeloid Leukemia

NCT06945042
active_not_recruitingphase_2

Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC

NCT03786692
recruitingphase_2

Tislelizumab Plus Concurrent Chemoradiation in Older With ESCC

NCT06061146
completedphase_1

A HR20031 BE Study on Healthy Subjects

NCT05682495
completednot_applicable

Using RCT to Increase Completion Rates of the Health Assessment Questionnaire.

NCT03435484
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT06945042Not Applicable

ONC-LEUK-2406: The Impact of Systematic Financial Navigation in Acute Myeloid Leukemia

Recruiting
NCT03786692Phase 2

Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC

Active Not Recruiting
NCT06061146Phase 2

Tislelizumab Plus Concurrent Chemoradiation in Older With ESCC

Recruiting
NCT05682495Phase 1

A HR20031 BE Study on Healthy Subjects

Completed
NCT03435484Not Applicable

Using RCT to Increase Completion Rates of the Health Assessment Questionnaire.

Completed
NCT05240521Not Applicable

Efficacy and Safety, Tolerability of GA-AT0119 in IBS-C

Unknown
NCT02079220Phase 2

A Phase II Study of Ziv-aflibercept in Combination With Capecitabine/Oxaliplatin (XELOX) Chemotherapy in the Front-Line Treatment of Patients With Metastatic Colorectal Cancer

Withdrawn
NCT01176799Phase 2

Randomized Study of Doxorubicin and Cyclophosphamide With or Without Intermittent Sunitinib in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer Patients With Measurable Primary Breast Tumor

Unknown
NCT01069081Phase 2

Docetaxel and Cisplatin Chemotherapy With or Without High Dose Proton Pump Inhibitor in Metastatic Breast Cancer

Completed
NCT02358720Phase 1

Single-fraction IMRT Versus External Beam Radiotherapy for Patients With Spine Bone Metastases

Unknown
NCT00756223Phase 1

Phase I Study of BI 831266 in Patients With Advanced Solid Tumours

Completed

All 11 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
11